Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)

Name: Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)
License: Public Domain

Fundacion Clinic per a la Recerca Biomédica · clinicaltrials

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hepatocellular-carcinoma

hepatocellular carcinoma

ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Record · ID 28459 · SHA-256 e5bfa50054351e7a
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.